These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26348837)

  • 21. Genetic control of organ-reactive autoantibody production in mice by obesity (ob) diabetes (db) genes.
    Yoon JW; Leiter EH; Coleman DL; Kim MK; Pak CY; McArthur RG; Roncari DA
    Diabetes; 1988 Sep; 37(9):1287-93. PubMed ID: 3044893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenalectomy suppresses insulin secretion from pancreatic islets of ob/ob mice.
    Okuda T; Romsos DR
    Int J Obes Relat Metab Disord; 1994 Dec; 18(12):801-5. PubMed ID: 7894518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Novel Genes Involved in Hyperglycemia in Mice.
    Jonas W; Kluth O; Helms A; Voß S; Jähnert M; Gottmann P; Speckmann T; Knebel B; Chadt A; Al-Hasani H; Schürmann A; Vogel H
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL; Liang Y; Cincotta AH
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin secretion and the morphological and metabolic characteristics of pancreatic islets of hyperthyroid ob/ob mice.
    Lenzen S; Klöppel G
    Endocrinology; 1978 Nov; 103(5):1546-55. PubMed ID: 371951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose utilization in relation to insulin secretion in NZO and C57Bl mouse islets.
    Larkins RG; Simeonova L; Veroni MC
    Endocrinology; 1980 Nov; 107(5):1634-8. PubMed ID: 6159204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elovl6 Deficiency Improves Glycemic Control in Diabetic
    Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
    Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disorganization of cytoplasmic Ca(2+) oscillations and pulsatile insulin secretion in islets from ob/ obmice.
    Ravier MA; Sehlin J; Henquin JC
    Diabetologia; 2002 Aug; 45(8):1154-63. PubMed ID: 12189446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin secretion from ob/ob mouse pancreatic islets: effects of neurotransmitters.
    Tassava TM; Okuda T; Romsos DR
    Am J Physiol; 1992 Mar; 262(3 Pt 1):E338-43. PubMed ID: 1550226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone-sensitive lipase deficiency suppresses insulin secretion from pancreatic islets of Lep ob/ob mice.
    Sekiya M; Yahagi N; Tamura Y; Okazaki H; Igarashi M; Ohta K; Takanashi M; Kumagai M; Takase S; Nishi M; Takeuchi Y; Izumida Y; Kubota M; Ohashi K; Iizuka Y; Yagyu H; Gotoda T; Nagai R; Shimano H; Yamada N; Kadowaki T; Ishibashi S; Osuga J
    Biochem Biophys Res Commun; 2009 Sep; 387(3):511-5. PubMed ID: 19619509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes.
    Bianchi MS; Bianchi S; Hernado-Insúa A; Martinez LM; Lago N; Libertun C; Chasseing NA; Montaner AD; Lux-Lantos VA
    Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E380-95. PubMed ID: 27329801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice.
    Toye AA; Lippiat JD; Proks P; Shimomura K; Bentley L; Hugill A; Mijat V; Goldsworthy M; Moir L; Haynes A; Quarterman J; Freeman HC; Ashcroft FM; Cox RD
    Diabetologia; 2005 Apr; 48(4):675-86. PubMed ID: 15729571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Islet proteomics reveals genetic variation in dopamine production resulting in altered insulin secretion.
    Mitok KA; Freiberger EC; Schueler KL; Rabaglia ME; Stapleton DS; Kwiecien NW; Malec PA; Hebert AS; Broman AT; Kennedy RT; Keller MP; Coon JJ; Attie AD
    J Biol Chem; 2018 Apr; 293(16):5860-5877. PubMed ID: 29496998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbon monoxide stimulates insulin release and propagates Ca2+ signals between pancreatic beta-cells.
    Lundquist I; Alm P; Salehi A; Henningsson R; Grapengiesser E; Hellman B
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1055-63. PubMed ID: 14534076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low.
    Chen NG; Tassava TM; Romsos DR
    J Nutr; 1993 Sep; 123(9):1567-74. PubMed ID: 8360782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression profiling of type 2 diabetes susceptibility genes in the pancreatic islets, adipose tissue and liver of obese mice.
    Morrison F; Locke J; Arif M; Murray A; Brown JE; Harries LW
    Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):413-9. PubMed ID: 23839539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.
    Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R
    Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand obese mouse (NZO/Hl)?
    Chankiewitz E; Peschke D; Herberg L; Bazwinsky I; Mühlbauer E; Brömme HJ; Peschke E
    Exp Clin Endocrinol Diabetes; 2006 May; 114(5):262-9. PubMed ID: 16804801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
    Garris DR; Garris BL
    Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.